Neuroimaging Study for Decoding Emotional States and Identifying Neural Circuits to Disengage Fro… (NCT06254144) | Clinical Trial Compass
CompletedNot Applicable
Neuroimaging Study for Decoding Emotional States and Identifying Neural Circuits to Disengage From Negative Thinking
United States89 participantsStarted 2024-01-10
Plain-language summary
The purpose of this study is to decode different thinking states from the brain activation patterns and identify the neural circuits that disengage from these thinking patterns using functional magnetic resonance imaging (fMRI) measurement in individuals with major depressive disorder.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Capable of understanding and complying with protocol requirements.
* Participants who are fluent and literate in English and are able to understand and provide written, informed consent and any required privacy authorization prior to the initiation of any study procedures.
* Male or female, 18 to 65 years.
* Current diagnosis of MDD who are currently depressed defined by the MINI.
* Participants who have moderate depressive symptoms (Patient Health Questionnaire: PHQ-9 ≥ 10 or Quick Inventory of Depressive Symptomatology: QIDS-SR ≥ 11).
Exclusion Criteria:
* Diagnosis of Schizophrenia spectrum or other psychotic disorders.
* Bipolar I Disorder.
* Active suicidal ideation with a plan and intent or suicidal ideation/attempts in the past 6-12 months.
* Current diagnosis of post-traumatic disorder (PTSD) defined by the MINI.
* Change in the dose or prescription of medication within the 6 weeks before enrolling in the study that could affect brain functioning.
* Moderate to severe substance use disorder within the last 12 months.
* A positive test for drugs of abuse, including but not limited to alcohol (breath test), cocaine, marijuana, opiates, amphetamines.
* Use of \> 400 mg caffeine or nicotine within the past 2 hours. Medical Conditions
* History of unstable liver or renal insufficiency.
* Significant and unstable cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurological, hematologic, rheumatologic, or metabolic disturbance.
* Moderate …
What they're measuring
1
Classification accuracy of different internal thoughts
Timeframe: 2 weeks
2
Changes in blood oxygen level-dependent (BOLD) signals across the whole brain during different internal thoughts and emotion regulation strategies.
Timeframe: 2 weeks
Trial details
NCT IDNCT06254144
SponsorLaureate Institute for Brain Research, Inc.